Richard P. Batycky
CIK 1646596 · Chief Tech. Off. & Site Head · last filed 2023-01-30
Richard P. Batycky is a Chief Tech. Off. & Site Head who has filed 10 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for PULM, was dated Jan 30, 2023. Across all open-market trades the lifetime net is −$41.9K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
10
-$41.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PULM | Director | — | $1.40 | — | $0 | 5 | 2023-01-30 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | Chief Tech. Off. & Site Head | 55,513 | $0.66 | $36.7K | -$41.9K | 5 | 2018-02-26 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-30 | PULM | Grant (A) | — | $0 | EDGAR |
| 2022-01-31 | PULM | Grant (A) | — | $0 | EDGAR |
| 2021-02-01 | PULM | Grant (A) | — | $0 | EDGAR |
| 2020-04-06 | PULM | Grant (A) | — | $0 | EDGAR |
| 2020-01-13 | PULM | Grant (A) | — | $0 | EDGAR |
| 2018-02-26 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +5,197 | $0 | EDGAR |
| 2017-05-03 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-03 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +4,400 | $0 | EDGAR |
| 2016-10-25 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −2,063 | -$41.9K | EDGAR |
| 2016-03-04 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |